EGFR signaling pathway as therapeutic target in human cancers
National Research Council · Harvard University · +4 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
324
total citations
- FWCI
- 42.61
- Percentile
- 100%
- References
- 433
Citations per year
Authors
4- ELElena LevantiniCorresponding
National Research Council, Harvard University, Institute of Biomedical Technologies, Harvard Stem Cell Institute
- GMGiorgia Maroni
Institute of Biomedical Technologies, National Research Council
- MDMarzia Del Re
University of Pisa
- DGDaniel G. TenenCorresponding
Harvard Stem Cell Institute, National University of Singapore, Harvard University
Topics & keywords
Topics
Keywords
- Cancer research
- Epidermal growth factor receptor
- Targeted therapy
- Cancer
- Signal transduction
- Biology
- Lung cancer
- Receptor tyrosine kinase
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.